ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*J2.0.21 - 2999001/03368080CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120230426W173deBibliographieenBibliographyfrBibliographieEP16861054.1201610312018052920201210enenen201562249216 P20151031US2023042620231720180905201836202303222023122022101320230426202317A61K 31/455 20060101AFI20190606BHEP A61K 45/06 20060101ALI20190606BHEP A61P 25/28 20060101ALI20190606BHEP C07C 57/03 20060101ALI20190606BHEP C07C 57/30 20060101ALI20190606BHEP C07C 57/50 20060101ALI20190606BHEP A61P 25/00 20060101ALI20190606BHEP A61P 25/16 20060101ALI20190606BHEP A61K 31/192 20060101ALI20190606BHEP A61K 31/198 20060101ALI20190606BHEP A61K 9/00 20060101ALI20190606BHEP A61K 9/48 20060101ALI20190606BHEP A61K 31/192 20130101 LI20181130BHEP A61K2300/00 20130101 LI20181130BHEP A61K 31/198 20130101 LI20181130BHEP A61K2300/00 20130101 LI20181130BHEP A61K 31/455 20130101 LI20190531BHEP A61K2300/00 20130101 LI20190531BHEP A61K 9/0019 20130101 LA20170609BHEP A61K 9/48 20130101 LA20170609BHEP A61K 45/06 20130101 LI20190531BHEP A61K 31/455 20130101 LI20190531BHEP A61P 25/00 20180101 LI20190531BHEP A61P 25/16 20180101 LI20190531BHEP A61P 25/28 20180101 LI20190531BHEP A61K 9/0043 20130101 LI20170504BHEP A61K 9/0053 20130101 LI20170504BHEP A61K 31/192 20130101 LI20170504BHEP A61K 31/198 20130101 FI20170504BHEP Y02A 50/30 20180101 LA20230209BGEP deBEHANDLUNG VON ERKRANKUNGEN DES NERVENSYSTEMS MITHILFE VON KOMBINATIONEN VON RXR-AGONISTEN UND SCHILDDRÜSENHORMONENenTREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONESfrTRAITEMENT DES TROUBLES DU SYSTÈME NERVEUX AU MOYEN DE COMBINAISONS D'AGONISTES DE PXR ET D'HORMONES THYROÏDIENNESEP-A1- 2 322 147EP-A1- 2 556 827WO-A1-2015/059632US-A1- 2004 147 611US-A1- 2009 227 674US-A1- 2009 227 674US-A1- 2015 038 585C. ASSAF ET AL: "Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion", BRITISH JOURNAL OF DERMATOLOGY, vol. 155, no. 2, 1 August 2006 (2006-08-01), pages 261-266, XP055586558, UK ISSN: 0007-0963, DOI: 10.1111/j.1365-2133.2006.07329.xAI LING FU ET AL: "Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease", NEUROPHARMACOLOGY., vol. 58, no. 4-5, 1 March 2010 (2010-03-01), pages 722-729, XP055593277, GB ISSN: 0028-3908, DOI: 10.1016/j.neuropharm.2009.12.020SHERMAN ET AL.: 'Central hypothyroidism associated with retinoid X receptor-selective ligands.' THE NEW ENGLAND JOURNAL OF MEDICINE, [Online] vol. 340, no. 14, 1999, pages 1075 - 1079, XP055379565 Retrieved from the Internet: <URL:http://www.nejm.org/doi/pdf/10.1056/NE JM199904083401404> [retrieved on 2016-12-12]20190613CHANDRARATNA, Roshantha, A.26242 Via CorrizoSan Juan Capistrano, CA 92675USSANDERS, Martin, E.1920 4th Avenue, No. 2704Seattle, WA 98101USIO Therapeutics, Inc.101931902SJM/P132116EP9450 Pinecroft Dr., Unit 9497Spring, TX 77387USMurgitroyd & Company101691439Murgitroyd House 165-169 Scotland StreetGlasgow G5 8PLGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201605977020161031enWO201707560720170504201718